Drug Trade Group Quietly Spends 鈥楧ark Money鈥 To Sway Policy And Voters
Grants by top pharma group to lightly regulated, politically active nonprofits dwarf its conventional campaign spending.
Drugs
961-980 of 1,313 results
-
-
Must-Reads Of The Week From Brianna Labuskes
KHN鈥檚 newsletter editor, Brianna Labuskes, wades through hundreds of health articles from the week so you don鈥檛 have to.
-
Podcast: KHN鈥檚 鈥榃hat The Health?鈥 Congress And Health Care. Again.
In this episode of KHN鈥檚 鈥淲hat the Health?鈥 Julie Rovner of Kaiser Health News, Anna Edney of Bloomberg News, Alice Ollstein of Talking Points Memo and Kimberly Leonard of the Washington Examiner talk about the new push on health legislation by Republicans in the House, as well as developments on Medicaid work requirements, drug prices and the fate of children separated from their parents at the U.S.-Mexican border. Plus, for extra credit, the panelists offer their favorite health stories of the week.
-
D茅j脿 Voodoo: Pharma鈥檚 Promises To Curb Drug Prices Have Been Heard Before
Several major drugmakers vow to contain drug prices, but similar pledges since the 1990s have not had much impact.
By Jay Hancock and Sarah Jane Tribble -
Purdue Pharma Edits Public Service Ad In Washington Post
Did OxyContin maker admit opioids can be dangerous even when patients take them as prescribed 鈥 then walk it back?
By Fred Schulte -
Must-Reads Of The Week From Brianna Labuskes
KHN鈥檚 newsletter editor, Brianna Labuskes, wades through hundreds of health articles from the week so you don鈥檛 have to.
-
Podcast: KHN鈥檚 鈥榃hat The Health?鈥 Drug Prices And Unicorns
In this episode of KHN鈥檚 鈥淲hat the Health?鈥 Julie Rovner of Kaiser Health News, Margot Sanger-Katz of The New York Times, Joanne Kenen of Politico, and Erin Mershon of Stat News discuss a series of health policy court decisions on everything from prescription drug discounts to soda taxes. Plus, Rovner, interviews health care futurist and consultant Jeff Goldsmith.
-
Staggering Prices Slow Insurers鈥 Coverage Of CAR-T Cancer Therapy
Some state Medicaid programs are not paying for the procedures, and Medicare鈥檚 complicated payment rates have hospitals concerned that it will not cover all the costs.
-
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don鈥檛 have to.
-
Podcast: KHN鈥檚 鈥榃hat The Health?鈥 ACA Under Fire. Again.
In this episode of KHN鈥檚 鈥淲hat the Health?鈥 Julie Rovner of Kaiser Health News, Margot Sanger-Katz of The New York Times, Anna Edney of Bloomberg News and Julie Appleby of Kaiser Health News discuss the health politics of the latest Supreme Court pick, as well as the Trump administration鈥檚 efforts to further undermine the Affordable Care Act. Plus, for extra credit, the panelists recommend their favorite health stories of the week.
-
Can Insurers Use Genetic Testing Results? A Reader Wants To Know
Other readers ask what can be done to challenge unexpected medical bills 鈥 whether the result of an emergency room visit or after a change in prescription drug coverage.
-
State Prisons Fail To Offer Cure To 144,000 Inmates With Deadly Hepatitis C
A survey of 49 states reveals that an estimated 144,000 inmates with hepatitis C, a curable but potentially fatal disease, can鈥檛 get the expensive drugs they need to cure it.
-
Podcast: KHN鈥檚 鈥榃hat The Health?鈥 Whither Work Requirements?
In this episode of KHN鈥檚 鈥淲hat the Health?鈥 Julie Rovner of Kaiser Health News, Joanne Kenen of Politico, Stephanie Armour of The Wall Street Journal and Anna Edney of Bloomberg News discuss the latest enrollment numbers for the Affordable Care Act, Medicaid work requirements in Kentucky and President Donald Trump鈥檚 proposed government reorganization plan. Plus, for extra credit, the panelists recommend their favorite health stories of the week.
-
Tennessee-Based Pain Management Group To Close Clinics Amid Financial Turmoil
The CEO of Comprehensive Pain Specialists was indicted in April. Now the group is closing clinics across several states.
By Fred Schulte -
Out-Of-Pocket Costs Put HIV Prevention Drug Out Of Reach For Many At Risk
It鈥檚 getting increasingly difficult for patients to afford Truvada, also known as pre-exposure prophylaxis, or PrEP, because of the drug鈥檚 high price and insurance company efforts to restrict the use of coupons that shield patients from it.
By Shefali Luthra and Anna Gorman -
Must-Reads Of The Week From Brianna Labuskes
KHN鈥檚 newsletter editor, Brianna Labuskes, wades through hundreds of health articles from the week so you don鈥檛 have to.
-
Top Policy Expert鈥檚 Ties To Giant Drugmaker Often Go Unstated
Dr. Mark McClellan joined Johnson & Johnson鈥檚 board of directors after leaving the FDA, but the connection often isn鈥檛 mentioned in research papers or public events.
-
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes, who reads everything on health care to compile our daily Morning Briefing, offers the best and most provocative stories for the weekend.
-
Doling Out Pain Pills Post-Surgery: An Ingrown Toenail Not The Same As A Bypass
As the opioid epidemic rages, a Johns Hopkins surgeon and researcher is leading an effort to curb overprescribing by offering procedure-specific guidelines to ensure that post-surgical patients leave the hospital with enough, but not too much, pain medication.
-
Purdue And The OxyContin Files
Purdue Pharma planned an extensive marketing campaign for the launch and promotion of the painkiller OxyContin. Here are Purdue鈥檚 internal budget documents from 1996 to 2002 鈥 files released by the Florida attorney general鈥檚 office 鈥 that detail the company鈥檚 early strategy to sell and expand use of the drug.